The basis for competition in healthcare is shifting dramatically at a pace not seen over the past 30 years. In the face of escalating costs, quality challenges and uneven access to care, under pressure from continued economic challenges in Europe and healthcare reform in the US, companies in all healthcare sectors are reassessing how best to serve and succeed in the market.

Through all the uncertainty, what is clear is that companies will need to demonstrate measurable value, embrace the changing role of the consumer in healthcare, and harness fast-paced big advances in medical science, if they are to succeed in addressing these challenges. These are not issues that will be solved by one segment of the industry alone. A deep understanding of all stakeholders, engagement beyond single sectors, new uses of technology, and an ability to innovate will be required.

In many growth markets governments are facing the challenge of providing access to care to millions of individuals. Significant infrastructure investments and new institutions are required. On the private side, tailored market approaches are needed to ensure successful market entry and profitable growth.

PwC’s strategy consulting team Strategy& works with leading healthcare organizations around the globe to navigate the different bases of competition and build the capabilities to deliver on that promise. Additional details on how we combine deep industry knowledge with extensive functional expertise to help our clients succeed can be found on our individual client pages: Payor, Health systems and other providers, Life sciences, Public health and Health NGOs and advocacy organizations.

2017 Life Sciences Trends
The New Health Economy is inspiring fresh ways to manage data, place a value on medical treatments and deal with empowered patients.
How Medicare Advantage Insurers Can Turn the Compliance Function into a Competitive Edge

Our thought leadership

Why Healthcare Companies Need to Focus on Enterprise Resilience
Pursuing effective growth strategies will help firms navigate the uncertainty in the U.S. market.
A critical makeover for pharmaceutical companies
It is time for pharmaceutical companies to restructure their operating models in a way that brings all of these interdependent functions together. They need to build the organisation around critical teams.
Pharma’s Identity Crisis
High blood pressure now affects more than 20 percent of the adult population around the world. Complications from the condition account for 9.4 million deaths a year, according to the World Health Organization.
Size should matter
Over the past two decades, U.S. hospitals have undergone a continuous wave of consolidation, seeking to become more profitable through mergers, partnerships, and other strategic alliances. The implicit logic of these...
Go big or go home
If hospitals and health systems are to unlock the full advantages of the bundled-care model, they will need to make a significant commitment to scale. Three complementary initiatives will bolster success in scaling up:...
Beyond the hospital walls
With every healthcare provider in the U.S. shifting to some form of value-based care, post-acute assets and capabilities will become a more integral part of any strategy. Playing in this space, however, requires...
Health systems and the IT transformation imperative
Health systems chief information officers must find the right balance between running the existing business and building new capabilities to help the business grow and adapt. By focusing on both efficiency and...
Staking Your Claim in the Healthcare Gold Rush
Revolutionary changes in the delivery, financing, and management of healthcare present a choice: Do you want to be a gold miner or a bartender?

read more health thought leadership >